Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants - Quiz - MDSpire

Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants

  • By

  • Ching-Hsuan Hsu

  • Ting-Yi Chang

  • Ya-Min Chang

  • Shin-Han Lin

  • Tzu-Ning Chen

  • Keng-Hao Hsu

  • Jhong-Jhe You

  • June 17, 2026

  • 0 min

Share

Original Source(s)

Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants

  • by Ching-Hsuan Hsu, Ting-Yi Chang, Ya-Min Chang, Shin-Han Lin, Tzu-Ning Chen, Keng-Hao Hsu, Jhong-Jhe You

  • June 17, 2026

Related Content

Glycemic variability and the short-term mortality of hospitalized patients with COVID-19: a meta-analysis

Acute pancreatitis temporally associated with COVID-19 pneumonia in a patient with post-tuberculosis chronic pulmonary aspergillosis: a case report

The immunopathological spectrum of COVID-19: from cytokine storm to autoimmunity—a systematic review